# Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders

> **NCT06980753** · NA · NOT_YET_RECRUITING · sponsor: **University of Sao Paulo General Hospital** · enrollment: 246 (estimated)

## Conditions studied

- Cushing Syndrome
- Primary Aldosteronism
- Adrenal Insufficiency

## Interventions

- **DEVICE:** Participants will use the biossensor for 48 h

## Key facts

- **NCT ID:** NCT06980753
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2025-11-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 246 (ESTIMATED)
- **Last updated:** 2025-05-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06980753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06980753, "Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06980753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*